Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3858981
Reference Type
Journal Article
Title
Hepatic Metabolism of Perfluorinated Carboxylic Acids: A Nuclear Magnetic Resonance Investigation In vivo
Author(s)
Reo, NV
Year
1995
Volume
GRA and I
Issue
21
Page Numbers
19
Abstract
Final technical rept. 15 Feb 90-14 Dec 94. eport outlines our progress regarding toxicological studies of perfluoro- n-octanoic acid (PFOA) and perfluoro-n-decanoic acid (PFDA). These Air Force chemicals belong to a class of compounds known as peroxisome proliferators (PP). Many PP cause hepatotoxicity and carcinogenesis in rodents. The mechanisms are unknown and represent an active area of research. Recent studies have demonstrated specific effects of PFDA treatment on hepatic phospholipid and carbohydrate metabolism. PFDA alters hepatic glucose transport. PFDA-treated rats showed rates of glucose transport which were 2-fold less than controls. PFDA treatment also caused a 3-fold increase in liver diacylglycerol (DAG): PFOA had no effect. This DAG is derived from phosphatidylcholine via phospholipase C activity. Since DAG stimulates protein kinase C (PKC), these data suggest that the hepatotoxic effects of PFDA may be initiated through a PKC response. Accordingly, experiments are in progress to investigate the effects of PFDA on liver PKC activity; preliminary data are presented herein. In other studies, preliminary data indicate that the influence of PFDA on phospholipid metabolism occurs at doses well below the LD50. Also, in studies involving C8-C11 perifluoro- carboxylic acids, only chain lengths > C9 affect phospholipid metabolism. These data suggest that the metabolic effects may be related to the compound's ability to diffuse into membranes. This research furthers our understanding of the mechanisms involved in the hepatotoxicity associated with these Air Force chemicals.
Keywords
In vivo analysis; Hepatitis; Toxicology; Carcinogenesis; Nuclear magnetic resonance; Chemicals; Enzymes; Metabolism; Transport; Toxic agents; Rodents; Air force equipment; Glucose; Fluorination; Carboxylic acids; Phospholipids; Carbohydrate metabolism; Perfiuoro n decanoic acid
Tags
PFAS
•
^Per- and Polyfluoroalkyl Substances (PFAS)
PFDA (335-76-2)
Literature Search
Toxline
•
PFAS 150
Literature Search August 2019
ToxNet
Not prioritized for screening
Perfluorodecanoic acid
Perfluorooctanoic acid
•
PFBA
Protocol References
•
PFDA
Literature Search
Toxline
Screening Results
Excluded/Not on Topic
Title and Abstract Screening
Excluded
Literature Searches (through April 2023 update and post-public comment/peer review)
Title & Abstract Screening
Excluded
Other
•
Yale PFAS Liver study
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity